John Greene Discover Financial Services (DFS) insider trading activity

John Greene is EVP, Chief Financial Officer of Discover Financial Services. Currently has a direct ownership of 79,866 shares of DFS, which is worth approximately $16 Million. The most recent transaction as insider was on Feb 01, 2025, when has been sold 1,840 shares (Common Stock) at a price of $201.09 per share, resulting in proceeds of $370,005. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 79.9K

20.14% 3M change

184.19% 12M change

Total Value Held $16 Million

John Greene Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2025	SELL Payment of exercise price or tax liability	$370,005 $201.09 p/Share	1,840 Reduced 2.25%	79,866 Common Stock
Jan 23 2025	BUY Grant, award, or other acquisition	-	14,630 Added 15.19%	81,706 Common Stock
Dec 19 2024	SELL Payment of exercise price or tax liability	$1,980,797 $169.27 p/Share	11,702 Reduced 14.85%	67,076 Common Stock
Dec 19 2024	BUY Grant, award, or other acquisition	-	12,109 Added 13.32%	78,778 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	38,375 Added 36.6%	66,478 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$1,309,622 $106.56 p/Share	12,290 Reduced 30.43%	28,103 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$1,309,622 $106.56 p/Share	12,290 Reduced 30.43%	28,103 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	21,801 Added 35.05%	40,393 Common Stock
Feb 01 2024	BUY Grant, award, or other acquisition	-	21,801 Added 35.05%	40,393 Common Stock
Jan 26 2024	SELL Open market or private sale	$3,748,193 $106.51 p/Share	35,191 Reduced 65.43%	18,592 Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	9,960 Added 15.69%	53,539 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$1,631,233 $115.83 p/Share	14,083 Reduced 24.42%	43,579 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	25,196 Added 30.41%	57,662 Common Stock
Aug 01 2022	SELL Payment of exercise price or tax liability	$179,089 $102.22 p/Share	1,752 Reduced 5.15%	32,275 Common Stock
Feb 25 2022	BUY Grant, award, or other acquisition	-	7,339 Added 17.77%	33,952 Common Stock
Feb 15 2022	SELL Open market or private sale	$568,482 $127.95 p/Share	4,443 Reduced 14.31%	26,613 Common Stock
Feb 01 2022	SELL Payment of exercise price or tax liability	$245,364 $118.02 p/Share	2,079 Reduced 6.27%	31,056 Common Stock
Aug 01 2021	SELL Payment of exercise price or tax liability	$217,809 $124.32 p/Share	1,752 Reduced 5.02%	33,135 Common Stock
Feb 19 2021	SELL Grant, award, or other acquisition	-	9,690 Reduced 21.74%	34,887 Common Stock
Feb 01 2021	SELL Payment of exercise price or tax liability	$94,190 $82.19 p/Share	1,146 Reduced 4.35%	25,197 Common Stock

Also insider at

CRSP

CRISPR Therapeutics AG Healthcare

John Greene

EVP, Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DFS shares.

Notify only if

Value

Insider Trading

Get notified when an Discover Financial Services insider buys or sells DFS shares.

Notify only if

Operation

Value

Type

News

Receive news related to Discover Financial Services

Track Activities on DFS

Account